Global Non-surgical Intragastric Balloon Market By Product Type, By Application, By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, and Forecast (2024 - 2031)

The "Non-surgical Intragastric Balloon Market" is focused on controlling cost, and improving efficiency. Moreover, the reports offer both the demand and supply aspects of the market. The Non-surgical Intragastric Balloon market is expected to grow annually by 11% (CAGR 2024 - 2031).

This entire report is of 120 pages.

Non-surgical Intragastric Balloon Introduction and its Market Analysis

The global Non-surgical Intragastric Balloon market research report provides insights into the current market conditions, focusing on the growth of this minimally invasive weight loss solution. Non-surgical Intragastric Balloon is a procedure where a balloon is inserted into the stomach to help patients lose weight. The target market for this procedure includes individuals looking for non-surgical weight loss options. Major factors driving revenue growth in the Non-surgical Intragastric Balloon market include increasing obesity rates and advancements in medical technology. Key players in the market include Allurion Technologies, Apollo Endosurgery, Endalis, Helioscopie, and ReShape Medical. The report recommends continued investment in research and development to drive further growth in the Non-surgical Intragastric Balloon market.

Get a Sample PDF of the Report: https://www.reliableresearchreports.com/enquiry/request-sample/684682

The non-surgical intragastric balloon market is experiencing rapid growth with increasing prevalence of obesity worldwide. The market is segmented into sterile and non-sterile types, catering to different patient needs. Hospitals, clinics, and other healthcare facilities are major application segments for intragastric balloons.

Regulatory and legal factors play a crucial role in shaping the market conditions. Health authorities in different countries have specific regulations in place for the use of intragastric balloons, ensuring patient safety and efficacy. Compliance with these regulations is essential for manufacturers and healthcare providers to operate in the market.

Overall, the non-surgical intragastric balloon market is poised for significant growth, driven by the increasing demand for minimally invasive weight loss procedures. Manufacturers are focusing on innovation and product development to meet the evolving needs of patients and healthcare providers. With stringent regulatory requirements and a competitive landscape, the market is expected to witness further advancements in the coming years.

Top Featured Companies Dominating the Global Non-surgical Intragastric Balloon Market

The non-surgical intragastric balloon market is a competitive landscape with several key players such as Allurion Technologies, Apollo Endosurgery, Endalis, Helioscopie, and ReShape Medical. These companies offer innovative solutions to help individuals achieve weight loss through the use of intragastric balloons, which are inserted into the stomach to create a feeling of fullness and reduce food intake.

Allurion Technologies is known for its Elipse Balloon System, which is the world's first and only swallowable intragastric balloon for weight loss. Apollo Endosurgery offers the Orbera Intragastric Balloon System, which is placed in the stomach for six months to help patients lose weight. Endalis, Helioscopie, and ReShape Medical also have their own variations of intragastric balloons to aid in weight loss.

These companies help grow the non-surgical intragastric balloon market by providing safe and effective weight loss solutions for individuals who may not be eligible for surgical procedures. By offering innovative and minimally invasive treatment options, these companies are able to cater to a wider range of patients seeking weight loss solutions.

In terms of sales revenue, Apollo Endosurgery reported revenue of $ million in 2020, while Allurion Technologies raised $27 million in Series C funding in 2020 to support the global commercial expansion of its Elipse Balloon System. These companies continue to invest in research and development to improve their products and expand their reach within the non-surgical intragastric balloon market.

• Allurion Technologies
• Apollo Endosurgery
• Endalis
• Helioscopie
• ReShape Medical

Get a Sample PDF of the Report: https://www.reliableresearchreports.com/enquiry/request-sample/684682

Non-surgical Intragastric Balloon Market Analysis, by Type:

• Sterile
• Non-sterile

Sterile Intragastric Balloons are pre-packaged and ready for immediate use, reducing the risk of infection during insertion. Non-sterile balloons require sterilization prior to insertion, offering a more cost-effective option. This variety in options caters to different healthcare settings and patient preferences, thus increasing access to non-surgical weight loss alternatives. The availability of both sterile and non-sterile options broadens the scope of patients who can benefit from the procedure, subsequently boosting the demand for Intragastric Balloons in the market.

Inquire or Share Your Questions If Any Before the Purchasing This Report -https://www.reliableresearchreports.com/enquiry/pre-order-enquiry/684682

Non-surgical Intragastric Balloon Market Analysis, by Application:

• Hospital
• Clinic
• Other

Non-surgical intragastric balloon is used in hospitals, clinics, and other medical facilities to aid weight loss in patients who are obese or overweight. The balloon is inserted into the stomach through an endoscopic procedure and filled with saline solution to create a feeling of fullness, helping patients eat less.

The fastest growing application segment in terms of revenue is clinics, as more and more individuals are seeking non-surgical weight loss solutions outside of traditional hospital settings. Clinics offer a more convenient and personalized approach to weight loss management, making them increasingly popular among patients.

Purchase this Report (Price 3250 USD for a Single-User License): reliableresearchreports.com/purchase/684682

Non-surgical Intragastric Balloon Industry Growth Analysis, by Geography:

North America:

• United States
• Canada

Europe:

• Germany
• France
• U.K.
• Italy
• Russia

Asia-Pacific:

• China
• Japan
• South Korea
• India
• Australia
• China Taiwan
• Indonesia
• Thailand
• Malaysia

Latin America:

• Mexico
• Brazil
• Argentina Korea
• Colombia

Middle East & Africa:

• Turkey
• Saudi
• Arabia
• UAE
• Korea

The non-surgical intragastric balloon market is experiencing significant growth in regions such as North America (United States, Canada), Europe (Germany, France, ., Italy, Russia), Asia-Pacific (China, Japan, South Korea, India, Australia, Indonesia, Thailand, Malaysia), Latin America (Mexico, Brazil, Argentina, Colombia), and Middle East & Africa (Turkey, Saudi Arabia, UAE). The market is expected to be dominated by North America and Europe, with a market share of around 50% and 20% respectively. Asia-Pacific is also expected to see significant growth, with a market share of around 15%, while Latin America and Middle East & Africa are expected to have smaller market shares.

Purchase this Report (Price 3250 USD for a Single-User License): reliableresearchreports.com/purchase/684682

Check more reports on reliableresearchreports.com